Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharma Exports to Touch $600M by 2010: Exporters (Pakistan)

This article was originally published in PharmAsia News

Executive Summary

Dr. Kaiser Waheed of the Pakistan Pharmaceutical Manufacturers Association (PPMA) says Pakistan has been building and expanding its drug-manufacturing units, pharmaceutical infrastructure, and export capabilities over the last decade, and soon will be poised to compete with China and India. He says Pakistan has a low-cost base for pharmaceuticals. Some industry officials claim Pakistan's pharmaceutical exports may total more than $600 million by 2010. That would be an increase from around $85 million today. Such a rapid expansion could occur only if Pakistan bans drug imports, says Waheed. In terms of exports, Pakistan's central geographical location should make export costs small to Asia and the Middle East. Pakistan already has experience providing drugs to highly organized markets, says the World Pharmaceutical Market 2007 report by RNCOS' Research Analyst. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066357

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel